This dual GIP/GLP-1 receptor agonist is administered as a once-weekly subcutaneous injection and must be obtained through legitimate healthcare channels
Finally, based on the noted beneficial effect, BPC 157 may balance collagen synthesis and affect hepatic fibrosis, as a model of the wound-healing response to chronic liver injury, which was modified (Albanis and Friedman, 2001
showed that BPC-157 significantly accelerated the healing of gastric ulcers induced by: Cysteamine Aspirin and NSAIDs Alcohol Chronic restraint stress Surgical resection The peptide not only accelerated healing rates but also improved the quality of healed tissue, reducing scarring and fibrosis [10]
These comparative safety differences make AOD-9604 potentially suitable for individuals who might not tolerate full growth hormone therapy or who have contraindications to traditional GH use
This poor oral bioavailability explains why clinical trials used subcutaneous injection
[9] Why can this medication give my breath or sweat a fishy smell